JOEL LECONTE: Open Payments
NPI 1356021554 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $205 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| AltaThera Pharmaceuticals LLC | 1 | $10 |
Products named: VYNDAQEL, LEQVIO, ELIQUIS, JARDIANCE, Kerendia, CAMZYOS, ONPATTRO, Sotalol Hydrochloride.
Industry payments across MA — which companies pay providers there.
